CXCR2 is a G protein-coupled receptor mediating chemotaxis in immune responses and is believed to play a key role in several inflammatory diseases including atherosclerosis. In man, CXCR2 is expressed in neutrophils, monocytes and macrophages and binds several chemokines such as CXCL8 (IL-8), CXCL1 (GROa), and CXCL5 (ENA78). Similarly in mice, a receptor homologous to human IL-8 (CXC chemokine ligand 8 [CXCL8]) receptor, or mouse CXCR2 (mCXCR2) is expressed in these neutrophils, monocytes and macrophages. mCXCR2 binds several CXCL8-like CXC chemokines, most notably KC and MIP-2. KC and MIP-2 are related to the 3 human GRO chemokines (CXCL1/3). [1] [2] [3] It has been demonstrated that KC and MIP-2 can bind to human CXCR2 (hCXCR2) with a similar affinity as for mCXCR2. 2, 4) We have previously generated hCXCR2 knockin (hCXCR2(ϩ/ϩ)) mice that carry hCXCR2 instead of its mouse homolog, and described the full characterization of this knockin model. 5) The phenotype of the hCXCR2(ϩ/ϩ) mouse in contrast to mCXCR2 knockout mice perfectly resembled that of wild-type mice, indicating that the hCXCR2 is capable of functionally replacing its mouse counterpart. One of the most potential advantages of generating this model is that it allows one to study the role of hCXCR2 in the development of diseases like atherosclerosis, rheumatoid arthritis and psoriasis in preclinical animal studies using either antibodies against hCXCR2 or human specific CXCR2 antagonists. However, before such studies can be planned, it should be demonstrated that hCXCR2 can functionally replace mCXCR2 in development of the chronic disease in mice. Therefore, we performed studies aimed at demonstrating that the latter is indeed true for atherosclerotic plaque formation in a preclinical animal model. As mouse models for atherosclerosis, two well-described ApoE(Ϫ/Ϫ) and LDLR(Ϫ/Ϫ) mice are known. 6, 7) Since our data for LDLR(Ϫ/Ϫ) mice indicate a prominent role for CXCR2 and its ligands in development of atherosclerosis as compared to ApoE(Ϫ/Ϫ) mice, the former model for atherosclerosis was chosen to study functional replacement of mCXCR2 by hCXCR2.
Atherosclerosis, a pathological remodeling of the arteries, is the underlying basis of myocardial infarction, stroke and peripheral artery disease. 8) Atherosclerosis can be considered as a form of chronic inflammation occurring within the artery wall. 8, 9) In the pathogenesis of atherosclerosis, monocyte recruitment and macrophage differentiation are shown to be crucial features. In fatty streaks, the earliest detectable lesions in atherosclerosis, macrophage-derived foam cells that differentiate from recruited blood monocytes are detected. Since CXCR2 is expressed in monocytes and macrophages and mediates migration of these cells to the site of inflammation, attention has been increasing on the crucial role of CXCR2 in atherogenesis in man. Indeed several investigators have reported the involvement of CXCR2 in the development of atherosclerosis in preclinical animal models. 6, 7) In this study, we sought to demonstrate functional validity of hCXCR2 in the development of atherosclerosis using a preclinical animal model in the LDLR(Ϫ/Ϫ) mice. Within the field of chemokine receptors, low molecular weight (LMW) antagonists often turn out to be specific for the human chemokine receptors. [10] [11] [12] This seriously hampers straightforward testing of such antagonists in animal models. Validation of functional replacement of hCXCR2 and demonstration of its role in the disease model opens the way The CXC chemokine receptor CXCR2 has been implicated in the pathogenesis of several chronic diseases including atherosclerosis. To enable animal studies towards understanding the role of human CXCR2 (hCXCR2) in disease development, we previously generated hCXCR2 knockin (hCXCR2(؉/؉)) mice. We have demonstrated that the phenotype and the acute immune response of the hCXCR2(؉/؉) mice was identical to that of wild-type mice, indicating that hCXCR2 indeed takes over the function of endogenous mouse CXCR2 (mCXCR2). In the present paper, we extend these findings by studying whether hCXCR2 functionally replaces the role of mCXCR2 in a chronic disease model for atherosclerosis. We first defined which of two well-described atherosclerosis models ( to test human specific LMW CXCR2 antagonists or antibodies against hCXCR2 in future studies.
MATERIALS AND METHODS

Animals and Husbandry
Male ApoE(Ϫ/Ϫ) and LDLR(Ϫ/Ϫ) mice were obtained from Jackson Laboratory (Bar Harbor, ME, U.S.A.). The hCXR2(Ϫ/Ϫ) mice were generated as previously described. 5) Animals were housed in macrolon cages (eight animals/cage) at 19-21°C; the relative humidity was 50-60%, and an artificial light cycle of 12 h alternating with 12 h darkness was offered. Standard pelleted food (SDS; Special Diet Services, Witham, U.K.) or high-cholesterol atherogenic diet (Harlan Teklad #94059) and water was provided ad libitum. The animals were regularly observed for any behavioral and physical abnormalities. All animal experiments were approved by the Organon Animal Ethics Committee.
Generation of hCXCR2(؉/؉)/LDLR(؊/؊) Mice
The hCXCR2(ϩ/ϩ) mice as previously generated 5) were mated with the LDLR(Ϫ/Ϫ) mice and tails of offspring were used for PCR genotyping. The primers to identify the mCXCR2 (5Ј-GCTCTGGCATGCCCTCTATTC-3Ј and 5Ј-GTCCATG-CTGATGCAGGCTA-3Ј), hCXCR2 (5Ј-CCCATGTGAAC-CAGAATCCC-3Ј and 5Ј-TCCGCCAGTTTGCTGTATTG-3Ј), LDLR (5Ј-TTGTGTGTGATGGAGACCGAG-3Ј and 5Ј-GCCGTCAACACAGTCGACAT-3Ј) and LDLR(Ϫ/Ϫ)(5Ј-GATTGGGAAGACAATAGCAGGCATGC-3Ј and 5Ј-GGC-AAGATGGCTCAGCAAGCAAAGGC-3Ј) were used. PCR conditions were 100 ng of each primer, 1 U Taq polymerase (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.), 200 mM each dNTP (Amersham Pharmacia Biotech), 1ϫ PCR buffer (Amersham Pharmacia Biotech) in 50 ml. Amplification was carried out using the following protocol: denaturing for 5 min at 94°C, followed by 30 cycles consisting of denaturing at 95°C for 30 s, annealing at 57°C (mCXCR2 and hCXCR2 alleles), 60°C (Neo), or 67°C (LDLR(Ϫ/Ϫ)) for 30 s and extension at 72°C for 1 min in a PerkinElmer DNA Thermal Cycler 9700. Samples were subsequently analyzed on 2% agarose gels. A 352-bp fragment for mCXCR2 allele, 514-bp fragment for hCXR2 allele, 1500 fragment for LDLR(Ϫ/Ϫ) allele and 161-bp for wildtype LDLR allele were generated.
Atherosclerosis Model In order to induce atherosclerosis, the previously described protocol for measurements of fatty streak in rabbit aortas 13) was used with adjustments for murine models. 14) Briefly, a group of 15 mice (7-10 weeks old) were placed on the atherogenic diet for a period of 5-16 weeks to induce atherosclerosis. The standard diet was used for control animals. At the end of the study, mice were anaesthetized and the abdominal cavity was opened to expose the iliac bifurcation. Whole blood was drawn through the iliac bifurcation (Ϯ0.5-1 ml). The thoracic cavity was opened, the heart was exposed and the heart and aorta were anterogradely perfused with PBS by placing the needle through the apex in the left ventricle. While flushing, the right atrium was cut open to improve the circulation of the PBS and to prevent recirculation. The aorta was exposed from the heart to the iliac bifurcation, minor branching arteries were cut off, and the adventitia was removed as much as possible. The dissected aortas were fixed in 2.0% paraformaldehyde for further histological processing. Alternatively, the aortas were snap-frozen in liquid nitrogen for RNA isolation, or placed in ice-cold (4°C) PBS for chemokine secretion measurements.
Histological Analyses The fixed aortas were cut open, starting at the inner curvature of the arch following the ventral side of the aorta. To obtain a flat preparation for imaging, a second incision was made along the outer curvature of the arch. The aortas were flushed in 0.9% NaCl (1 min) and in ethanol 50% (1 min), stained in Sudan IV solution (1 min), flushed again in ethanol 70% (30 s) and then placed in 2.0% fixative. Finally, the samples were bedded in Glycerin/gelatine (37°C) between an object slide and a cover slip with the lumen side facing the cover slip. Colour photographs of each aorta sample were taken and the percentage of coverage with plaques was assessed by using imaging analyses (Context Vision Systems AB).
Real-Time PCR Assay To determine expression of mCXCR2 and its ligands (KC and MIP-2) in atherosclerotic lesions, the aortas were isolated from the ApoE(Ϫ/Ϫ) and the LDLR(Ϫ/Ϫ) mice and immediately snap-frozen with liquid nitrogen to preserve RNA quality. The pooled aortas (5 samples) were homogenised, total RNA was extracted and purified using Trizol (GIBCO BRL) and RNeasy Mini kit (QUIAGEN Inc.), and reverse transcribed using Superscript II (Gibco BRL). For PCR amplification, 2XTaqman Universal mastermix was used and the reaction was performed using ABI Prism 7000HT Sequence Detection System (Applied Biosystems). We used Pre-developed Taqman ® assay reagents for GAPDH (Applied Biosystems, 4310884E) and mCXCR2 (Applied Biosystems, 4312897P). For KC, a set of forward primer (GTTGCCCTCAGGGCCC), reverse primer (CCTCGCGACCATTCTTGAGT) and probe (CTGCACC-CAAACCGAAGTCATAGCCA(5Ј-FAM reporter, 3Ј-TAMRA quencher)) was used. For MIP-2, a set of forward primer (GCCCCCAGGACCCCA), reverse primer (CTTTT-TGACCGCCCTTGAGA) and probe (TGCGCCCAGACA-GAAGTCATAGCCA (5Ј-FAM reporter, 3Ј-TAMRA quencher)) was used. The reaction conditions were 50°C for 2 min, 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. The calculated copy numbers of mCXCR2, KC or MIP-2 were normalized to calculated GAPDH copy numbers in the same reaction and data were represented as relative expression.
Ex Vivo Secretions of CXC Ligands (KC and MIP-2) from Cultured Aortas To investigate secretion of CXCR2 ligands (KC and MIP-2) from atherogenic lesions, aortas were isolated from the LDLR(Ϫ/Ϫ) mice placed on an atherogenic diet (16 weeks). The healthy aortas were isolated for a comparison from control animals placed on the standard diet. The isolated aortas were cut and placed immediately in 1 ml ice-cold PBS to wash out residual ligands and then subsequently transferred to 1 ml of pre-warmed (37°C) DMEM medium and incubated. After 1 h of incubation at 37°C, supernatant was collected and levels of KC and MIP-2 were determined using commercially available specific ELISA kit (R&D Systems). The resulting levels (total production/aorta) were normalized to the levels in control group and data were represented as a percentage relative to the control (non-atherosclerotic) group.
Statistical Analyses Data are expressed as the meanϮS.D. Statistical significance was determined using Student's t-test; *pϽ0.05 was considered to be a statistically significant difference.
RESULTS
LDLR(؊/؊) versus ApoE(؊/؊) Mice
In order to investigate the functional role of hCXCR2 in the development of atherosclerosis, hCXCR2(ϩ/ϩ) mice on an atherosclerosis-prone background have to be generated. We firstly determined which atherosclerosis model (LDLR(Ϫ/Ϫ) vs. ApoE(Ϫ/Ϫ) mice) is most suited for follow up experiments. A crucial role for CXCR2 has been demonstrated in both the LDLR(Ϫ/Ϫ) and the ApoE(Ϫ/Ϫ) mice. 6, 7) We investigated whether CXCR2 and its ligands are expressed in atherosclerotic aorta in these two mice models. As shown in Fig. 1A , the LDLR(Ϫ/Ϫ) mice on the atherogenic diet showed plaque formation in the aorta while mice on the standard diet showed hardly any plaque formation. The ApoE(Ϫ/Ϫ) mice on the standard diet showed spontaneous plaque formation, which was further enhanced when mice were placed on the atherogenic diet (Fig. 1A) . For both LDLR(Ϫ/Ϫ) and ApoE(Ϫ/Ϫ) mice, these results are in line with previously reported data. 15, 16) When expression of CXCR2 and its ligands (KC and MIP-2) was determined in the aorta of both mice using a real-time PCR assay, a clear increase of CXCR2 and its ligands transcripts was observed in the LDLR(Ϫ/Ϫ) mice on the atherogenic diet as compared to LDLR(Ϫ/Ϫ) mice on the standard diet (Figs. 1B-D) . In contrast, expression levels of CXCR2, MIP-2 and KC were not increased in the ApoE(Ϫ/Ϫ) mice on the atherogenic diet (Figs. 1B-D) . Thus, plaque formation in the ApoE(Ϫ/Ϫ) mice on the atherogenic diet was not associated with increased expression of either mCXCR2 or its ligands. Taken together, these results suggest that CXCR2 and its ligands play a controlling role in the formation of plaque in LDLR(Ϫ/Ϫ) mice compared to ApoE(Ϫ/Ϫ) mice.
Secretion of CXC Chemokines in Cultured Aortas
To further confirm the possible roles of the CXCR2/KC and CXCR2/MIP-2 axis in the atherogenesis in the LDLR(Ϫ/Ϫ) mice, atherogenic aortas isolated from LDLR(Ϫ/Ϫ) mice placed on the atherogenic diet were cultured for 1 h at 37°C and secretion of CXCR2 ligands (KC and MIP-2) at protein level in these aortas was determined. Healthy non-atherogenic aortas were isolated for a comparison from control animals placed on the standard diet. As shown in Figs. 2A and B, aortas from the LDLR(Ϫ/Ϫ) mice placed on an atherogenic diet showed 38% and 120% increase in levels of KC and MIP-2 secretion, respectively as compared to levels in healthy control aortas. These data indicate that atherosclerotic aortas in the LDLR(Ϫ/Ϫ) mice do produce higher levels of CXCR2 ligands, which might facilitate recruitment of CXCR2 expressing monocytes to atherosclerotic lesions. The latter could play a role in driving the progression of chronic inflammation and foam cell formation in plaques of The aortas were isolated from the LDLR(Ϫ/Ϫ) mice placed on atherogenic diet (16 weeks, nϭ9). Samples were cut and washed in ice-cold PBS, and then placed in culture medium (37°C; 5% CO 2 ) for 1 h. The secretions of KC and MIP-2 from the aorta were measured using specific ELISA kits. The healthy aortas were isolated for a comparison from control animals placed on the standard diet. Data were normalized and expressed as a percentage relative to the control levels. Data represent meanϮS.D. * * pϽ0.01 (Student's t-test).
Fig. 1. Comparison of Plaque Formation (A) and Expression of mCXCR2 (B), MIP-2 (C) and KC (D) in ApoE(Ϫ/Ϫ) and LDLR(Ϫ/Ϫ) Mice Placed on Standard or Atherogenic Diet
Fifteen male mice were placed on the standard or atherogenic diet for a period of 16 weeks. At the end of study, aorta samples were isolated and each parameter was measured as described in Materials and Methods. Five aorta samples were pooled and assayed for relative expression of mCXCR2, MIP-2 and KC. Data represent meanϮS.D. these mice. These results taken together with the realtime PCR data (Figs. 1B-D) indeed support the role of CXCR2 and its ligands in the development of atherosclerosis in the LDLR(Ϫ/Ϫ) mice. Based on this set of data, the LDLR(Ϫ/Ϫ) mice were used to mate with the hCXCR2(ϩ/ϩ) mice.
Generation of hCXCR2(؉/؉)/LDLR(؊/؊) Mice
In order to generate hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice, hCXCR2(ϩ/ϩ) mice and LDLR(Ϫ/Ϫ) mice were mated. The second generation of mice was PCR genotyped and further mating of the offspring was performed until generation of the objective mice, in which the mCXCR2 gene is replaced by hCXCR2 gene and the LDLR gene is totally disrupted (hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice). As shown in Fig. 3 , genotype comparison of wild-type and the hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice indeed showed identification of 514 bp hCXCR2 PCR fragment and 1500 bp LDLR(Ϫ/Ϫ) PCR fragment accompanied with absence of 352 bp mCXCR2 PCR fragment and 161 bp LDLR PCR fragment in the hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice. These founder mice were further mated to expand the colony and to obtain sufficient numbers of animals for further studies. During breeding processes, these mice appeared to breed normal and did not show any obvious abnormalities under the standard husbandry conditions. Atherosclerosis in LDLR(؊/؊) versus hCXCR2(؉/ ؉)/LDLR(؊/؊) Mice To investigate whether hCXCR2 can functionally replace mCXCR2 in chronic atherosclerosis, plaque density was quantified in aortas from LDLR(Ϫ/Ϫ) mice and hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) double mutant mice that were placed on either standard or an atherogenic diet for a period of 16 weeks. For this comparison, male animals were used since females were shown to be less susceptible to atherosclerosis. 17) In the LDLR(Ϫ/Ϫ) mice, atherosclerotic plaque formation was detected when mice were placed on the atherogenic diet (Fig. 4A) . In agreement with previous results, no lesions were detected in mice on the standard diet. 16) Similarly to the LDLR(Ϫ/Ϫ) mice, the hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice on the standard diet did not show any sign of atherosclerosis (Fig. 4B) . In contrast, clear induction of atherosclerotic lesions were detected in the hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice when mice were put on the atherogenic diet. As shown in Fig. 4 , plaque area in hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice was within the same order as was detected in LDLR(Ϫ/Ϫ) mice. In addition, histological analyses of lesions in isolated aortas of the hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice demonstrated well-defined histological features as previously reported by several investigators using the LDLR(Ϫ/Ϫ) mice 6, 18) (data not shown). In view of the previously reported strong (Ͼ60%) inhibition of plaque formation in LDLR(Ϫ/Ϫ) mice that lack mCXCR2 in bone marrow cells, 6) we conclude that hCXCR2 is capable of functionally replacing mCXCR2 in a mouse model of atherosclerosis.
Kinetics of Plaque Formation Finally, to further characterize development of atherosclerosis in the CXCR2(ϩ/ϩ)/ LDLR(Ϫ/Ϫ) mice, time-course analyses of plaque formation were performed in female and male animals. As shown in Fig. 5 , both female and male CXCR2(ϩ/ϩ)/ LDLR(Ϫ/Ϫ) mice showed plaque formation when placed on the atherogenic diet for a period of 5 weeks. In male animals, further increase in plaque area was observed at 8, 10 and 12 weeks. In contrast, no further increase in plaque area was observed in female animals. These data agree with previous reports stating that male mice are more prone to development of atherosclerosis than female mice. 17, 19) The data furthermore implies that in future experiments, when efficacy of LMW CXCR2 antagonists or antibodies against hCXCR2 are tested, the effect on plaque formation could be quantified as early as 8-10 weeks after placing male hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice on the atherogenic diet.
DISCUSSION
We have previously shown that hCXCR2 replaces the function of mCXCR2 in hCXCR2 knockin mice. 5) This was demonstrated since the phenotype of hCXCR2 knockin mice was similar to that of wild-type mice. In the present study, we aimed to further validate the hCXCR2 knockin model by studying whether hCXCR2 is also functional in a chronic disease model. We have chosen to study the role of hCXCR2 in plaque formation in LDLR(Ϫ/Ϫ) mice because it has been published that absence of mCXCR2 strongly and significantly reduces plaque formation in those mice. Our finding, that plaque formation in hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice is similar to that in LDLR(Ϫ/Ϫ) mice clearly indicates that hCXCR2 is able to take over mCXCR2 in this chronic inflammatory condition. This now opens the way to study efficacy in vivo of compounds or antibodies designed to antagonize hCXCR2 in a model for atherosclerosis.
Firstly, we investigated and compared expression of CXCR2 and its ligands in atherosclerotic lesions in two atherosclerosis-prone mouse models, the LDLR(Ϫ/Ϫ) and ApoE(Ϫ/Ϫ) mice, using real-time QPCR assays. Our results demonstrated a significant expression of CXCR2 and its ligands in atherosclerotic lesions of the LDLR(Ϫ/Ϫ) mice placed on the atherogenic diet. This indicates a clear role for CXCR2 and its ligands in the development of atherosclerosis in these mice. Further, these data are in line with the previously reported finding that plaque formation is considerably reduced when bone marrow of the LDLR(Ϫ/Ϫ) mice is reconstituted with that of CXCR2(Ϫ/Ϫ) mice.
6) It was also reported recently that arterial KC and leukocyte-specific CXCR2 expression are central to macrophage accumulation in established fatty streak lesions in the LDLR(Ϫ/Ϫ) mice. 20) These findings, together with our data, strongly support an involvement of CXCR2 and its ligands in the development of atherosclerosis in the LDLR(Ϫ/Ϫ) mice.
Our data for ApoE(Ϫ/Ϫ) mice indicate a less prominent role for CXCR2 and its ligands in development of atherosclerosis in this model. However, previously a role for KC in triggering monocyte arrest on atherosclerotic endothelium has been reported to occur at a very early stage of atherosclerosis in the ApoE(Ϫ/Ϫ) mice. 7) Although our data appear contradictory to the previous report, we cannot exclude the possibility that the expression of mCXCR2 and its ligands was missed because their expression was only measured at 16 weeks after placing mice on an atherogenic diet. However, our data comparing LDLR(Ϫ/Ϫ) and ApoE(Ϫ/Ϫ) mice for CXCR2 involvement prompted us to study the role of hCXCR2 in LDLR(Ϫ/Ϫ) mice rather than in ApoE(Ϫ/Ϫ) mice.
Several investigators have documented that female animals are less susceptible to atherosclerosis development in preclinical animal models due to the atheroprotective effect of estrogens. 17, 19) For estrogens, this mode of action for the atheroprotective effects could be further supported by the evidence that exogenous estrogens can also strongly attenuate atherosclerotic lesion formation in male mice. 21) In this study, female hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice also showed significantly less formation of plaques as compared to male animals. Recently, Lei et al. very clearly demonstrated that both basal and hypercholesterolemia-induced increases in chemokine receptor CXCR2 expression on monocytes are attenuated by physiological concentrations of estradiol 22) in rats. They proposed this finding as one of the potential mechanisms by which estrogens retard atherogenesis. If this effect of estrogens is mediated through CXCR2, our data suggest that this inhibitory pathway is intact in female hCXCR2(ϩ/ϩ)/LDLR(Ϫ/Ϫ) mice.
Cardiovascular disease is the leading source of morbidity, disability, and mortality in Western industrialised countries, and atherosclerosis is the main underlying pathology. Therefore, urgent demands for novel and potent therapeutics for the disease are increasing. Several chemokine/chemokine receptor axes including IL-8(CXCL8)/CXCR2 have been implicated in the processes of inflammation and platelet activation and adhesion, thus contributing to atherosclerosis. 23, 24) There is increasing evidence that modulation of the cellular signaling processes by either inhibiting chemokines or their receptors may be an effective strategy for the treatment of atherosclerosis. 25) Here we generated hCXCR2(ϩ/ϩ)/ LDLR(Ϫ/Ϫ) mice that develop atherosclerosis on an atherogenic diet. This model will allow testing antibodies against hCXCR2 or hCXCR2 specific LMW antagonists in a mouse model. We strongly believe this approach will turn out to be crucial in the development of novel therapeutics designed to antagonize specifically hCXCR2 in the future.
